Medicare is the nation’s health care program for citizens aged 65 years and up, and younger people who meet certain eligibility criteria. Medicare Part A, Part B, Part C, and Part D cover many major medical expenses for participants. Choosing the right Medicare plan can be confusing, and it may be difficult to decipher all
0 Comments
Shares in hair care products company Olaplex (NASDAQ:OLPX) dropped more than 40% in pre-market trading today after the company cut sales projections. A press release estimates 2022 sales of $704 million to $711 million, and adjusted net income of $303 million to $307 million. Estimates released with its August quarter earnings were for sales of
0 Comments
This is Part Two of our list of suggested year-end strategies. Part 1 discusses gaming the federal standard deduction, and managing capital gains and losses. The tax environment is getting friendlier for workers. With year-end rapidly approaching, it’s time to consider moves that will lower your 2022 tax bill and hopefully position you for tax
0 Comments
Chamath Palihapitiya, Social Capital Founder and CEO CNBC A new buyback tax has motivated more and more SPAC sponsors to close up shop before the year-end, adding another headwind to the blank-check space already roiled by a tough market environment. A total of 27 SPAC deals, worth $12.8 billion, have been liquidated this year, according
0 Comments
In many if not most cases, investors should recognize that you get what you pay for, although in rare moments, market participants can get away with bargain stocks to buy for under $10. To be clear, price rarely stands as the end-all, be-all for equity-based opportunities. You must conduct thorough research before putting your hard-earned
0 Comments
Key Takeaways Tesla produced 365,923 vehicles in Q3, an increase of almost 54% compared from the year-ago quarter and above analyst predictions. Tesla made more vehicles than it delivered, signaling a potential backlog. Tesla’s profit beat analyst estimates, while revenue came in below predictions. Tesla Earnings Results Metric Beat/Miss/Match Reported Value Analysts’ Prediction Adjusted Earnings
0 Comments
Increased spending by consumers means there’s increased fraud activity. Here’s some tips to avoid falling victim to cyber fraud during the holiday shopping season. “Cybercrime has gotten more sinister and significant,” said head of Citibank’s fraud prevention unit Mike Steinbach. “The American public needs to know fraud has evolved. You shouldn’t be waiting on monthly,
0 Comments
U.S. investors have been tentative in investing in Chinese securities of late. That is mainly because of the increased volatility due to country-specific risks and a worldwide economic slowdown. Consequently, many Chinese tech stocks are now trading at a hefty bargain, offering attractive entry points for traders and investors. Over the past couple of years,
0 Comments
When it comes to managing your life as a retiree, it almost goes without saying that you’ll need to keep abreast of the yearly Social Security tweaks and adjust your budget accordingly. However, with so much new information to keep track of, it can be easy to forget some of the smaller details, such as
0 Comments
Cannabis stocks have been crushed this year due to the lack of progress on the federal legalization of marijuana and macro challenges. However, President Joe Biden’s historic decisions to pardon people convicted of “simple possession of marijuana” and to review the classification of marijuana as a Schedule 1 drug have revived investors’ attention in the cannabis
0 Comments
In this article CL Follow your favorite stocksCREATE FREE ACCOUNT Daniel Loeb Simon Dawson | Bloomberg | Getty Images Dan Loeb’s Third Point has built a sizeable stake in consumer giant Colgate-Palmolive, according to CNBC’s David Faber. Loeb sees hidden value in Colgate’s subsidiary, Hill’s Pet Nutrition, a pet food company, if it were spun
0 Comments
With all the vagaries in the market these days, investors may be better served considering undervalued biotech stocks to buy. At the most basic level, biotechnology firms aim to address critical vulnerabilities in the human condition. Therefore, while the sector certainly features a profit motivation, it generally falls under a feel-good framework. To be fair,
0 Comments